myelodysplastic syndromes
In this study, we found that the patients of both myelodysplastic syndromes and chronic myeloid leukaemia with BMI1 overexpression had a higher risk in malignant myeloid progression.
In this study, we found that the patients of both <span class="disease" id="24571310-3-50-75">myelodysplastic syndromes</span> and chronic myeloid leukaemia with <span class="gene" id="24571310-3-111-115">BMI1</span> overexpression had a higher risk in malignant myeloid progression.